Abbott’s test may identify infections faster
Abbott announced initial results that suggest its innovative testing platform, known as IRIDICA (currently in development),…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research Archive
US FDA approves Cyramza for stomach cancer
The US Food and Drug Administration has approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or…
USFDA advisory committee votes against approval of Novartis RLX030
RLX030 is under review to improve the symptoms of AHF by reducing of the rate of worsening of heart failure
Childhood flu shots could result in serious clinical outcomes in adults: Study
Review studies show pneumococcal serotypes infecting adults are changing globally following widespread paediatric PCV vaccination…
NPScreen develops NPC screening test
A Markham, Ontario-based company has developed a specialised test which screens for nasopharyngeal cancer
Phase III psoriasis data show significant skin clearance with Novartis secukinumab
Patient-reported outcomes from Feature and Juncture show high patient satisfaction with secukinumab PFS and AI self-administration…
Lallemand declares results of on-going AIACE(1) study
Prof M Cazzola presents positive immunological study at a workshop on lung health
’Biologic molecules are complex’
Ashleigh Wake, the Biotechnology Programme Manager, Intertek Pharmaceutical Services Manchester, talks about different aspects…
Genetically engineered livestock – new technologies, new opportunities
Prof Bruce Whitelaw, Genus Chair of Animal Biotechnology, The Roslin Institute, University of Edinburgh, Visiting Fellow, DBT…
Sunshine Biopharma begins construction of mouse xenograft models for pancreatic cancer
To advance Adva-27a as a treatment for this deadly form of cancer